| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 2.357 | 12.014 | 15.470 | 21.524 | 20.731 | 35.250 | 38.719 | 40.544 |
| Total Income - EUR | - | - | 2.357 | 12.014 | 15.470 | 21.524 | 20.731 | 35.250 | 38.719 | 40.544 |
| Total Expenses - EUR | - | - | 2.313 | 8.814 | 10.410 | 19.627 | 14.548 | 25.595 | 24.730 | 28.961 |
| Gross Profit/Loss - EUR | - | - | 44 | 3.200 | 5.059 | 1.897 | 6.182 | 9.655 | 13.989 | 11.584 |
| Net Profit/Loss - EUR | - | - | -27 | 2.897 | 4.705 | 1.693 | 5.975 | 9.302 | 13.652 | 10.548 |
| Employees | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Erianmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 16.987 | 15.497 | 13.217 |
| Current Assets | - | - | 408 | 3.276 | 6.067 | 7.705 | 7.468 | 6.795 | 8.327 | 19.775 |
| Inventories | - | - | 0 | 93 | 79 | 632 | 157 | 1.060 | 3.363 | 3.111 |
| Receivables | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 121 | 0 |
| Cash | - | - | 408 | 3.183 | 5.988 | 7.073 | 7.312 | 5.735 | 4.842 | 16.664 |
| Shareholders Funds | - | - | 17 | 2.914 | 5.547 | 7.135 | 6.945 | 16.269 | 21.785 | 22.160 |
| Social Capital | - | - | 44 | 43 | 843 | 827 | 809 | 811 | 809 | 804 |
| Debts | - | - | 391 | 362 | 520 | 570 | 524 | 7.524 | 2.051 | 10.832 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Erianmed S.r.l.